-- 
BioScrip, DineEquity, Forest Oil, Vishay: U.S. Equity Movers

-- B y   I n y o u n g   H w a n g   a n d   N i k o l a j   G a m m e l t o f t
-- 
2011-05-03T15:29:55Z

-- http://www.bloomberg.com/news/2011-05-02/anadarko-herbalife-local-com-parexel-u-s-equity-preview.html
Shares of the following companies are
having unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 11:10 a.m. in  New York .  Advanced Energy Industries Inc. (AEIS)   gained 13 percent
to $15.32 after rallying as much as 14 percent, the most
intraday July 22. The maker of power conversion systems forecast
second-quarter earnings of as much as 44 cents a share, above
the average analyst estimate of 38 cents a share in a Bloomberg
survey.  Avon Products Inc. (AVP)   increased 5 percent to $31.05,
the most intraday since Oct. 27. The world’s largest door-to-
door cosmetics merchant reported first-quarter sales of $2.63
billion. On average, the analysts surveyed by Bloomberg
projected revenue of $2.59 billion.  BioScrip Inc. (BIOS)   surged 22 percent to $5.50, after
rallying as much as 35 percent, the most intraday since October
2008. The Elmsford, New York-based pharmacy-benefits manager
reported first-quarter adjusted earnings of 5 cents, beating the
average analyst estimate of 1 cent.  Bridgepoint Education Inc. (BPI)   rose 9.4 percent to
$20.12 and touched $21.08 earlier, the highest intraday price
since Nov. 2. The for-profit provider of college classes
forecast earnings in 2011 of at least $2.47 a share, topping the
$2.26 average estimate by analysts.  Chesapeake Energy Corp. (CHK)   fell 5.4 percent, the most
intraday since March 10, to $31.45. The most-active U.S.
natural-gas driller reported a first-quarter loss after losing
$725 million on energy hedging contracts.  Computer Sciences Corp. (CSC)   fell 13 percent, the most
in the  S&P 500 , to $43.84. The provider of computer services to
companies and U.S. government agencies said full-year sales and
profit probably missed its forecasts.  DineEquity Inc. (DIN)   rose 3.7 percent to $51.65 and
gained 9.7 percent earlier, the most intraday since Feb. 4. The
restaurant company reported first-quarter earnings excluding
some items of $1.42 a share, beating the average analyst
estimate by 22 percent, according to Bloomberg data.  FirstEnergy Corp. (FE)   climbed 5 percent, the second-
most in the Standard & Poor’s 500 Index, to $41.58. The owner of
utilities in Ohio, Pennsylvania and  New Jersey  said that,
excluding some items, it expects to earn $3.20 to $3.50 a share
this year. That topped the average analyst estimate of $3.17 in
a Bloomberg survey.  Forest Oil Corp. (FST)   slumped 8 percent to $32.90,
after falling to $32.05, the lowest intraday price since Nov. 3.
The Denver-based oil and gas company reported first-quarter
adjusted earnings of 19 cents a share, missing the 34-cent
average estimate by analysts.  Herbalife Ltd. (HLF)   rallied 12 percent, the most in the
Russell 1000 Index, to $101.25. The seller of nutritional and
weight-loss supplements forecast second-quarter profit of as
much as $1.48 a share, exceeding the average analyst estimate of
$1.44 in a Bloomberg survey.  Kulicke & Soffa Industries Inc. (KLIC)   jumped 15 percent
to $10.35 and reached $10.46 earlier, the highest intraday price
since Feb. 1. The maker of semiconductor assembly equipment
forecast sales in the third quarter of at least $255 million,
beating the average analyst estimate of $199 million.  Local.com Corp. (LOCM)   declined 18 percent, the second-
most in the  Russell 2000  Index, to $3.68. The operator of an
Internet search engine that helps users find local businesses
forecast a second-quarter loss of 12 cents a share. Analysts in
a Bloomberg survey estimated a profit of 7 cents a share on
average.        MetroPCS Communications Inc. (PCS)   rose 8.3 percent, the
most in the S&P 500, to $17.85. The pay-as-you-go mobile-phone
carrier reported first-quarter revenue of $1.2 billion, beating
the average analyst estimate in a Bloomberg survey by 6 percent.  NetLogic Microsystems Inc. (NETL)   dropped 7.6 percent to
$40 after losing 8.6 percent earlier, the most intraday since
Jan. 20. The developer of semiconductors reported first-quarter
revenue of $98.7 million, missing the average analyst estimate
by 1.8 percent.  Parexel International Corp. (PRXL)   fell 17 percent, the
most in the Russell 2000, to $22.41. The tester of experimental
medicines for drug-makers forecast 2011 earnings of no more than
94 cents a share excluding some items, missing the average
analyst estimate of $1.21 a share, according to a Bloomberg
survey.  Pfizer Inc. (PFE)   slid 3 percent, the most in the Dow
Jones Industrial Average, to $20.40. Lipitor, the world’s
biggest drugmaker’s cholesterol pill, had sales of $2.39 billion
in the first quarter, falling short of the $2.55 billion average
estimate of five analysts surveyed by Bloomberg. Sales will
decline by more than half next year after generic-drug makers
flood the U.S. market with cheaper copies, according to eight
analysts surveyed.  Sears Holdings Corp. (SHLD)   lost 8.7 percent, the
second-most in the S&P 500, to $76.85. The largest U.S.
department-store chain said domestic first-quarter comparable-
store sales fell 3.6 percent, led by declines in appliances,
apparel and consumer electronics.  Sykes Enterprises Inc. (SYKE)   climbed 8 percent to
$21.50 and touched $22.88 earlier, the highest intraday price
since April 2010. The operator of call centers forecast revenue
in the second quarter of at least $305 million, exceeding the
average analyst estimate of $304.4 million.  Vishay Precision Group Inc. (VPG)   rallied 9.8 percent to
$18.08, after gaining 16 percent, the most intraday since Aug.
3. The designer of foil technology products forecast second-
quarter revenue of at least $58 million, topping the average
analyst estimate of $55.8 million.  To contact the reporters on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net ;
Nikolaj Gammeltoft in New York at 
 ngammeltoft@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 